Skip Navigation LinksHome > October 2012 - Volume 34 - Issue 7 > Cutaneous Reactions to Novel Therapeutics
Text sizing:
American Journal of Dermatopathology:
doi: 10.1097/DAD.0b013e31822e67eb
CME Article

Cutaneous Reactions to Novel Therapeutics

Hoang, Mai P. MD*; Kroshinsky, Daniela MD

Continued Medical Education
Collapse Box


Abstract: In the last 2 decades the introduction new biologic agents such as tumor necrosis factor alpha inhibitors has resulted in potent disease modifying effects in a variety of immune-mediated diseases. In addition, there were major advancements in cancer treatment due to chemotherapeutic agents including granulocyte macrophage-colony-stimulating factor, interferon, epidermal growth factor receptor inhibitors, and kinase inhibitors for the treatment of hematologic malignancies as well as solid tumors. However, a variety of toxicities including cutaneous reactions is seen in association with these agents. Awareness of commonly associated skin toxicities and recognition of corresponding histologic features is of importance.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.